Potential drugs for improving chronic fatigue syndrome.
Hoseini
Sayed Shahabuddin
SS
Gharibzadeh
Shahriar
S
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D015673:Fatigue Syndrome, Chronic / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents; D000069285:Infliximab; D013792:Thalidomide / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D013792:Thalidomide; D000069285:Infliximab